Overview
Michal Wagrodzki practices in Warsaw, Poland. Wagrodzki is highly rated in 6 conditions, according to our data. Their top areas of expertise are Adult Soft Tissue Sarcoma, Melanoma, Chondrosarcoma, and Epithelioid Sarcoma.
Their clinical research consists of co-authoring 32 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult Soft Tissue SarcomaWagrodzki isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Advanced
- Alveolar Soft Part SarcomaWagrodzki isAdvanced. Learn about Alveolar Soft Part Sarcoma.
- ChondrosarcomaWagrodzki isAdvanced. Learn about Chondrosarcoma.
- Epithelioid SarcomaWagrodzki isAdvanced. Learn about Epithelioid Sarcoma.
- LiposarcomaWagrodzki isAdvanced. Learn about Liposarcoma.
- MelanomaWagrodzki isAdvanced. Learn about Melanoma.
- Experienced
- Bannayan-Riley-Ruvalcaba SyndromeWagrodzki isExperienced. Learn about Bannayan-Riley-Ruvalcaba Syndrome.
- Bone TumorWagrodzki isExperienced. Learn about Bone Tumor.
- ChordomaWagrodzki isExperienced. Learn about Chordoma.
- Clear Cell SarcomaWagrodzki isExperienced. Learn about Clear Cell Sarcoma.
- Cowden SyndromeWagrodzki isExperienced. Learn about Cowden Syndrome.
- Ewing SarcomaWagrodzki isExperienced. Learn about Ewing Sarcoma.